Moxisylyte (Thymoxamine)
An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Also Known As:
Thymoxamine; Acetoxythymoxamine; Carlytène; Icavex; Moxisylyte Hydrochloride; Hydrochloride, Moxisylyte; Thymoxyalcylamine; Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester)
Networked: 89
relevant articles (5 outcomes,
10 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Fan, Yue:
1 article
(01/2021)
|
2. | Hu, Xiaomin:
1 article
(01/2021)
|
3. | Li, Hanyu:
1 article
(01/2021)
|
4. | Sun, Yueshen:
1 article
(01/2021)
|
5. | Zhang, Shuyang:
1 article
(01/2021)
|
6. | Zhao, Xinyue:
1 article
(01/2021)
|
7. | Zhou, Ruilin:
1 article
(01/2021)
|
8. | Boiteau, F:
1 article
(02/2001)
|
9. | Boyer, F:
1 article
(02/2001)
|
10. | Dizien, O:
1 article
(02/2001)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures